{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:15Z","timestamp":1788967875786,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-YBSF-374"],"award-info":[{"award-number":["2023-YBSF-374"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amepre.2023.05.007","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T02:16:58Z","timestamp":1683857818000},"page":"818-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cost-Effectiveness of Recombinant Zoster Vaccine for Adults Aged \u226550 Years in China"],"prefix":"10.1016","volume":"65","author":[{"given":"Minghuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinke","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.amepre.2023.05.007_bib0001","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.amepre.2023.05.007_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/749698","article-title":"The societal impact of herpes zoster and postherpetic neuralgia on patients, life partners, and children of patients in Germany","volume":"2014","author":"Weinke","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0004","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","article-title":"Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey","volume":"6","author":"Oster","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.amepre.2023.05.007_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.amepre.2023.05.007_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14787210.2020.1792290","article-title":"A systematic literature review to assess the burden of herpes zoster disease in China","volume":"19","author":"Yin","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.amepre.2023.05.007_bib0007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12879-017-2198-y","article-title":"Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.amepre.2023.05.007_bib0008","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","article-title":"Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean-A systematic review and meta-analysis","volume":"31","author":"Bardach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.amepre.2023.05.007_bib0009","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","article-title":"Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amepre.2023.05.007_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jinf.2013.06.016","article-title":"A population based study of the epidemiology of Herpes Zoster and its complications","volume":"67","author":"Weitzman","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.amepre.2023.05.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100145","article-title":"Incidence trend and disease burden of seven vaccine-preventable diseases in Shandong Province, China, 2013\u20132017: findings from a population-based observational study","volume":"10","author":"Li","year":"2022","journal-title":"Vaccine X"},{"key":"10.1016\/j.amepre.2023.05.007_bib0012","unstructured":"National Bureau of Statistics. China Statistical [Yearbook]. http:\/\/www.stats.gov.cn\/tjsj\/ndsj\/2021\/indexch.htm. Accessed November 8, 2022."},{"issue":"11","key":"10.1016\/j.amepre.2023.05.007_bib0013","first-page":"2632","article-title":"A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China","volume":"14","author":"Lu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10.1016\/j.amepre.2023.05.007_bib0014","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amepre.2023.05.007_bib0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amepre.2023.05.007_bib0016","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14760584.2021.1954910","article-title":"Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50\u201369 years","volume":"20","author":"Lu","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.amepre.2023.05.007_bib0017","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1080\/21645515.2021.1960137","article-title":"Low willingness to vaccinate against herpes zoster in a Chinese metropolis","volume":"17","author":"Lu","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.amepre.2023.05.007_bib0018","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.vaccine.2020.01.093","article-title":"Influenza vaccination rate and its association with chronic diseases in China: results of a national cross-sectional study","volume":"38","author":"Fan","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.amepre.2023.05.007_bib0019","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1080\/21645515.2021.1932216","article-title":"Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing","volume":"17","author":"Lee","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.amepre.2023.05.007_bib0020","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/cid\/ciab629","article-title":"The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal Phase 3 clinical trials ZOE-50 and ZOE-70","volume":"74","author":"Boutry","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.amepre.2023.05.007_bib0021","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/21645515.2017.1345399","article-title":"Assessment of the potential public health impact of Herpes Zoster vaccination in Germany","volume":"13","author":"Curran","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"31","key":"10.1016\/j.amepre.2023.05.007_bib0022","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.vaccine.2018.06.049","article-title":"Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong","volume":"36","author":"You","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0023","first-page":"475","article-title":"Incidence of herpes zoster in Yichang city of China in 2016","volume":"9","author":"Lu","year":"2019","journal-title":"Chin J Viral Dis"},{"issue":"2","key":"10.1016\/j.amepre.2023.05.007_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jinf.2020.12.013","article-title":"Incidence and disease burden of herpes zoster in the population aged \u226550 years in China: data from an integrated health care network","volume":"82","author":"Sun","year":"2021","journal-title":"J Infect"},{"issue":"22","key":"10.1016\/j.amepre.2023.05.007_bib0025","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0026","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2340\/00015555-0729","article-title":"Epidemiological features and costs of herpes zoster in Taiwan: A national study 2000 to 2006","volume":"89","author":"Jih","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.amepre.2023.05.007_bib0027","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/erp.13.19","article-title":"Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis","volume":"13","author":"Bresse","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.amepre.2023.05.007_bib0028","first-page":"432","article-title":"Epidemiological characteristics of herpes zoster in urban areas of Yichang city during 2016\u20132017 based on the Yichang Big Data Platform for Health Management","volume":"25","author":"Jiang","year":"2019","journal-title":"Chin J Vaccines Immunization"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0029","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s13555-022-00744-8","article-title":"Cost-effectiveness analysis update of the adjuvanted recombinant zoster vaccine in Japanese older adults","volume":"12","author":"Teng","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.amepre.2023.05.007_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.puhe.2015.10.009","article-title":"Social networks and health-related quality of life among Chinese old adults in urban areas: results from 4th National Household Health Survey","volume":"131","author":"Lei","year":"2016","journal-title":"Public Health"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0031","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: Using national measures to create condition-specific values","volume":"36","author":"Gold","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0032","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s12325-021-01717-7","article-title":"Economic burden and impact on quality of life of herpes zoster in Spanish adults aged 50 years or older: A prospective cohort study","volume":"38","author":"D\u00edez-Domingo","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.amepre.2023.05.007_bib0033","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1477-7525-12-92","article-title":"Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study","volume":"12","author":"Serpell","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.amepre.2023.05.007_bib0034","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00019053-200826030-00006","article-title":"Community and patient values for preventing herpes zoster","volume":"26","author":"Lieu","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.amepre.2023.05.007_bib0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jcma.2017.06.024","article-title":"Cost-effectiveness analysis of endoscopic tympanoplasty versus microscopic tympanoplasty for chronic otitis media in Taiwan","volume":"81","author":"Tseng","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.amepre.2023.05.007_bib0036","article-title":"Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine program for the elderly aged 60 years or older in Shanghai, China","volume":"9","author":"Sun","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.amepre.2023.05.007_bib0037","unstructured":"Data Yao Zhi. https:\/\/db.yaozh.com\/yaopinzhongbiao. Accessed November 8, 2022."},{"issue":"5","key":"10.1016\/j.amepre.2023.05.007_bib0038","first-page":"503","article-title":"Analysis of herpes zoster incidence and hospitalization in three areas of Beijing in 2015 based on health information system of medical institutions","volume":"53","author":"Suo","year":"2019","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.amepre.2023.05.007_bib0039","first-page":"308","article-title":"Retrospective investigation of the onset of herpes zoster cases, Ning'an city","volume":"33","author":"Gao","year":"2017","journal-title":"Chin J Public Health Manag"},{"issue":"4","key":"10.1016\/j.amepre.2023.05.007_bib0040","article-title":"Disease burden due to herpes zoster among population aged \u226550 years old in China: A community based retrospective survey","volume":"11","author":"Li","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.amepre.2023.05.007_bib0041","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/CEOR.S203920","article-title":"Patient and economic burdens of postherpetic neuralgia in China","volume":"11","author":"Yu","year":"2019","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.amepre.2023.05.007_bib0042","series-title":"Health Commission of China. China Health Statistical Yearbook","year":"2021"},{"issue":"5","key":"10.1016\/j.amepre.2023.05.007_bib0043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ane.13485","article-title":"Direct economic burden of patients with tuberculous meningitis in western China","volume":"144","author":"Ma","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.amepre.2023.05.007_bib0044","first-page":"119","article-title":"Study of incidence and economic burden of herpes zoster based on community investigation among the aged in Laiwu district, Jinan city, Shandong Province of China","volume":"56","author":"Zhang","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0045","first-page":"736","article-title":"Economic burden and health-related quality of life of herpes zoster disease in rural areas of Jiangsu Province","volume":"26","author":"Wang","year":"2022","journal-title":"Chin J Dis Control Prev"},{"key":"10.1016\/j.amepre.2023.05.007_bib0046","unstructured":"National Bureau of Statistics. National data. https:\/\/data.stats.gov.cn\/easyquery.htm?cn=C01. Accessed November 8, 2022."},{"key":"10.1016\/j.amepre.2023.05.007_bib0047","unstructured":"National Bureau of Statistics. Statistical Bulletin of National Economic and Socialhttp:\/\/www.stats.gov.cn\/tjsj\/zxfb\/202202\/t20220227_1827960.html. Accessed November 8, 2022."},{"issue":"11","key":"10.1016\/j.amepre.2023.05.007_bib0048","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.amepre.2023.05.007_bib0049","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.agecon.2003.11.006","article-title":"World health report. Reducing risks, promoting healthy life","volume":"30","author":"Mutangadura","year":"2002","journal-title":"Agric Econ"},{"issue":"6","key":"10.1016\/j.amepre.2023.05.007_bib0050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/M18-2347","article-title":"A cost-effectiveness analysis of vaccination for prevention of herpes zoster and related complications: input for national recommendations","volume":"170","author":"Prosser","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2023.05.007_bib0051","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamainternmed.2017.7431","article-title":"Cost-effectiveness of the adjuvanted herpes zoster subunit vaccine in older adults","volume":"178","author":"Le","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"33","key":"10.1016\/j.amepre.2023.05.007_bib0052","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1016\/j.vaccine.2018.07.005","article-title":"Cost-effectiveness of an adjuvanted Recombinant zoster Vaccine in older adults in the United States","volume":"36","author":"Curran","year":"2018","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.amepre.2023.05.007_bib0053","doi-asserted-by":"crossref","first-page":"E932","DOI":"10.1503\/cmaj.190274","article-title":"Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study","volume":"191","author":"Drolet","year":"2019","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.amepre.2023.05.007_bib0054","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-018-1213-5","article-title":"Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines","volume":"16","author":"de Boer","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.amepre.2023.05.007_bib0055","unstructured":"Drug clinical trial registration and information disclosure platform. http:\/\/www.chinadrugtrials.org.cn\/clinicaltrials.searchlist.dhtml. Accessed November 8, 2022."},{"key":"10.1016\/j.amepre.2023.05.007_bib0056","unstructured":"Drug Evaluation Center. NMPA. https:\/\/www.cde.org.cn\/main\/xxgk\/listpage\/2f78f372d351c6851af7431c7710a731. Accessed November 8, 2022."},{"issue":"1","key":"10.1016\/j.amepre.2023.05.007_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210005","article-title":"Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults","volume":"14","author":"You","year":"2019","journal-title":"PLOS ONE"},{"issue":"19\u201320","key":"10.1016\/j.amepre.2023.05.007_bib0058","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.amepre.2023.05.007_bib0059","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"Melegaro","year":"2018","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.amepre.2023.05.007_bib0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:09:40Z","timestamp":1760083780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379723002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0749379723002258"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2023.05.007","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Recombinant Zoster Vaccine for Adults Aged \u226550 Years in China","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2023.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}